Division of Cardiovascular Medicine Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan.
Division of Cardiovascular Medicine Osaka Saiseikai Nakatsu Hospital Osaka Japan.
J Am Heart Assoc. 2021 Aug 3;10(15):e020243. doi: 10.1161/JAHA.120.020243. Epub 2021 Jul 26.
Background Although patients with a cancer history have a 2 to 3 times higher risk for acute coronary syndrome (ACS), the morphological characteristics of ACS culprit plaque in those patients and their relations with clinical outcomes remain unknown. Methods and Results This retrospective, multicenter, observational cohort study included consecutive patients with ACS who underwent optical coherence tomography-guided emergent percutaneous coronary intervention. Patients were categorized into those without a cancer history, those with a cancer history, and those currently receiving cancer treatment. ACS culprit lesions were classified as plaque rupture, plaque erosion, or calcified nodule using optical coherence tomography. Plaque erosion frequency was significantly higher in culprit lesions of patients with current cancer and patients with cancer history than in those of patients without cancer history (56.3% versus 61.7% versus 36.5%). Calcified nodule incidence was significantly higher in patients without cancer history than in patients with current cancer and patients without cancer history (patients with current cancer: 12.4% versus patients without cancer history: 25.5% versus patients without cancer history: 12.6%, <0.001). Cancer history was independently associated with nonplaque rupture (plaque erosion or calcified nodule) in ACS culprit lesions (odds ratio, 4.00; <0.001). Cancer history was independently associated with major adverse cardiovascular events (hazard ratio [HR], 1.98; =0.002). Nonplaque rupture in ACS culprit lesions was independently associated with major adverse cardiovascular events (HR, 1.60; =0.011). Conclusions Patients with a cancer history had significantly worse clinical outcomes after ACS than those without a cancer history. Those with a cancer history had significantly higher plaque erosion and calcified nodule incidences in the ACS culprit lesions, which might partly explain their worse clinical outcomes. Registration URL: www.umin.ac.jp/ctr/index.htm. Unique Identifier: UMIN000038442.
背景 尽管有癌症病史的患者发生急性冠状动脉综合征(ACS)的风险高 2 至 3 倍,但这些患者 ACS 罪犯斑块的形态特征及其与临床结局的关系尚不清楚。
方法和结果 本回顾性、多中心、观察性队列研究纳入了接受光学相干断层扫描(OCT)指导的紧急经皮冠状动脉介入治疗的连续 ACS 患者。患者分为无癌症史、有癌症史和正在接受癌症治疗的患者。使用 OCT 将 ACS 罪犯病变分为斑块破裂、斑块侵蚀或钙化结节。结果发现,在有当前癌症和有癌症史的患者的罪犯病变中,斑块侵蚀的频率显著高于无癌症史的患者(分别为 56.3%、61.7%和 36.5%)。在无癌症史的患者中,钙化结节的发生率显著高于有当前癌症和无癌症史的患者(有当前癌症的患者:12.4%;无癌症史的患者:25.5%;无癌症史的患者:12.6%,<0.001)。癌症史与 ACS 罪犯病变中非斑块破裂(斑块侵蚀或钙化结节)独立相关(比值比,4.00;<0.001)。癌症史与主要不良心血管事件(MACE,HR,1.98;=0.002)独立相关。ACS 罪犯病变中的非斑块破裂与主要不良心血管事件(HR,1.60;=0.011)独立相关。
结论 与无癌症史的患者相比,有癌症史的 ACS 患者的临床结局明显较差。有癌症史的患者在 ACS 罪犯病变中斑块侵蚀和钙化结节的发生率明显更高,这可能部分解释了他们较差的临床结局。
UMIN000038442。